Literature DB >> 12607157

Pattern of antibiotic use in a trachoma-endemic region of Nepal: implications for mass azithromycin distribution.

Vivian Schiedler1, Ramesh C Bhatta, Yinghui Miao, Mariko Bird, Hem Jha, J S P Chaudary, Alicia M Fry, Thomas M Lietman.   

Abstract

PURPOSE: To investigate antibiotic utilization in a rural district of western Nepal that is currently receiving azithromycin as part of a trachoma program and is being monitored by the Centers for Disease Control and Prevention (CDC) for drug resistance.
METHODS: Antibiotic purchase receipts were collected for 3 months from all medicine halls, pharmacies, and government sub-health posts in a sub-district of Western Nepal. Supplementary surveys of antibiotic sales were performed in different seasons.
RESULTS: Macrolides account for 3.9% of total antibiotic use, far less than quinolones, penicillins, tetracyclines, and sulfonamides.
CONCLUSIONS: If trachoma programs in Western Nepal generate transient macrolide resistance in pneumococcus and other bacteria, the epidemiological impact may not be great, as macrolides are not commonly used in the area.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12607157     DOI: 10.1076/opep.10.1.31.13772

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  3 in total

1.  Topical ocular antibiotics induce bacterial resistance at extraocular sites.

Authors:  B D Gaynor; J D Chidambaram; V Cevallos; Y Miao; K Miller; H C Jha; R C Bhatta; J S P Chaudhary; S Osaki Holm; J P Whitcher; K A Holbrook; A M Fry; T M Lietman
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

Review 2.  Strategies to control trachoma.

Authors:  Anu A Mathew; Angus Turner; Hugh R Taylor
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

3.  Trachoma decline and widespread use of antimicrobial drugs.

Authors:  Jaya D Chidambaram; Mariko Bird; Vivian Schiedler; Alicia M Fry; Travis Porco; Ramesh C Bhatta; Hem Jha; J S P Chaudary; Bruce Gaynor; Elizabeth Yi; John P Whitcher; Susie Osaki-Holm; Thomas M Lietman
Journal:  Emerg Infect Dis       Date:  2004-11       Impact factor: 6.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.